![Ronald Crystal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Crystal
Gründer bei
Xylocor Therapeutics, Inc.
Profil
Ronald G.
Crystal is the founder of GenVec, Inc. (1992), Xylocor Therapeutics, Inc. (2013), and Lexeo Therapeutics, Inc. (2017).
At Xylocor Therapeutics, Inc., he holds the title of Director.
Dr. Crystal is currently the Chairman of Genetic Medicine at Weill Cornell Medical College.
Crystal is also the founder of Annapurna Therapeutics SAS.
Aktive Positionen von Ronald Crystal
| Unternehmen | Position | Beginn |
|---|---|---|
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Gründer | 01.01.2013 |
Ehemalige bekannte Positionen von Ronald Crystal
| Unternehmen | Position | Ende |
|---|---|---|
| GENVEC INC | Gründer | - |
| LEXEO THERAPEUTICS, INC. | Gründer | - |
Annapurna Therapeutics SAS
 Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
